Insurance companies are hurting from the high cost of hepatitis C drug Sovaldi. Arthur Caplan, NYU Langone Medical Center, and CNBC's Bertha Coombs, share their opinions.» Read More
Friday--today--is the last day of Trading With The Stars--and only transactions that were input by 4 pm ET Thursday will make a difference in their standings. As the Dow fell almost 150 points, Ernie Hudson was the only celeb to show a portfolio gain Thursday--on Gmarket. Jonathan Tucker regained the top spot, and Stephen Collins fell back into second on heavy losses in Golden Telecom. Meanwhile, Chris Moneymaker got crushed on Allscripts Healthcare, which has cost him $181,862.60 since he purchased it on 5/8, and he is now in last place. James Cromwell was hit hard by Knot Inc. which cost him $160K dropping him from 4th to 8th.
Wow--can Stephen Collins pick em or not. As we mentioned in an earlier post on contest stocks--best performong stock Foster Wheeler let the actor soar into first place in Trading With The Stars--with a $78K gain on FWLT--which was up 19.96% Wednesday. He now has a total portfolio value of $1,237,825.31 which gives him a $14K lead over Jonathan Tucker with 2 days remaining in the contest. Lots of hooray's for Stephen from the "Morning Call" Team--the show he's playing for.
Well, our contest "stock report" has some interesting news. One of the best performers was a stock (FWLT) that celeb/actor Stephen Collins had on his list--and one that put him in the lead of Trading With The Stars (more on that in another post). In fact, it was the best of the best performers. And one pick that made the most actives, was one recommended yesterday by guest blogger Timothy Sykes--SIX. Here you go...
As I write this, Dendreon is about to cross the 100,000,000 trading volume threshold. If Cisco hadn't made news as well, DNDN would easily be the most active stock on any of the major exchanges today. Yesterday the FDA sent Dendreon what's called an "approvable letter". I've called it a euphemism for "delay", but essentially it means the agency says it might eventually approve a product if or when the company provides whatever other information it wants.
The top 4 celebrities remain constant with Jonathan Tucker holding onto his lead with only $62,581.29 separating him from Stephen Collins. Poker champion Moneymaker is betting on Allscripts Healthcare to move him up from 4th on strong earnings after the bell Tuesday. And Hall of Famer Johnny Bench is counting on American Oriental Bioengineering to continue to perform--as he's in 5th place.
Hey folks. Jeff Mishlove is here with his picks today. Let's get right to his post: This has been a very busy time for me, so I am submitting this blog a bit later than usual. However, the lateness allows me to see that the picks I recommended for yesterday are doing quite well. Two of the five are among the top two eligible stocks for the contest on Tuesday. Those are aQuantive and Blue Nile – up, as I am writing, 11.98% and 17.21% respectively.
We have an earnings video news report by CNBC/Wall Street Journal Editor Bob O'Brien. Bob looked at three companies--Disney, CVS Caremark and Molson-Coors. Disney reports after the bell today and CVS has already reported. Molson has yet to.
It's do or die time for our celebs as this is the final week of Trading With The Stars, so here are the standings. Jonathan tucker holds on to the lead with a total portfolio value of $1,198,400.00 which is down $25 from Thursday's total. Stephen Collins continues in the #2 spot with a total portfolio value of $1,160,007.02 up more than $41K from Thursday's total and is now within about $38K from the top.
Hey everyone, here's Jeff Mishlove with his latest round of contest stock picks. He seems to be doing pretty well with his picks. Are you? Here he is: As I reported in Friday’s blog, and earlier, Week 8 of the contest was a thrilling experience for me – as I ended up on the weekly leaderboard in second place – with a portfolio that appreciated 112.98% for the week.
The actors have been doing pretty well lately in Trading With The Stars, but the non-acting celebs are making a move--including Johnny Bench (so, his picture gets posted). Jonathan Tucker still holds first place on modest gains in Washington Grp and Starwood Hotels. Stephen Collins takes back 2nd place on gains in Emergency Medical Services up 10.13% Thursday. But poker champ Chris Moneymaker moves from 8th to 5th on a 2.73% gain in Gigamedia..
Wow--actor Ernie Hudson pulled out all the stops (thus his picture gets listed) and jumped from 4th into 2nd place in Trading With The Stars. This continues his momentous climb as he had previously moved from 8th to 4th. So Ernie is definitely on a roll or donut -or just plain getting some great advice. Ernie knocks fellow actor Stephen Collins into 4th place behind James Cromwell, while Jonathan Tucker keeps a hold on 1st place. And Johnny Bench might take a few lessons from Ernie. The Hall of Fame catcher keeps 10th place very warm!
Hey folks, we have some info on the weekly leader we can pass along. At this point, the current weekly leader is Alejandro Garcia--tracking at about a 90% gain and is currently all in cash. He has made two trades this week. (This is not to declare ANYONE a weekly winner yet)
Hi all. Here's a report that ran on CNBC-TV today that might be of interest. It's money manager Mike Koskuba of Victory Capital Management on stocks he thinks have a great upside coming to them--and stock holders. Now, these are not necessarily for you to add to your contest picks (or your personal portfolio) and you might to get tremendous gains, but they are some stocks to think about.
Here's our latest contest stock report. Once again, earnings--good and bad--are playing apart in what's making you "money" or not. If you had Amazon, you saw the good, while owners of Travelzoo saw the bad--and ugly, from earnings. Also, there's a new name on the most active list--as a results of earnings--Sun Microsystems. Here ya go with the details:
Eli Lilly announced Wednesday it has received approval from the FDA to market Reconcile, the first selective serotonin reuptake inhibitor (SSRI) class of antidepressants approved by the FDA for treatment of canine separation anxiety in conjunction with behavior modification training.
Hey folks. We have guest blogger Jeff Mishlove with his contest stock picks for today. Jeff's been putting a lot of work into this--especially with earnings season upon on--but as he says, he really enjoys the process--and we really appreciate having him. Remember, as Jeff says, he can be right on a stock, or sometimes "not so right." It's an imperfect science, even for the best of analysts. There's a lot to factor in, but that's just what Jeff's doing for us. Here's his post:
Here's our re-cap of today with the leaderboard, most active and widely held as well as the trivia questions. (we have video of all this below). The video question is worth $2,000 Bonus Bucks: According to the Alix Partners brand survey, which company was voted the least trusted brand in America? Your selection of answers is: Microsoft or Kraft or Ford or Sony.
Here's a look at the latest contest stock action. Mergers and acquisitions played a strong part in the best performers (MedImmune, Baush & Lomb) as well as earnings figures (Angiodynamics). A couple of newer names showed up in the most active list (Ligand and Angiotech) while the widely held stocks stayed the same.
Good morning. We have a big change on the leaderboard. Kevin Boyd jumps from 4th place to take the lead after gaining over $419K with Gentex Corp. Serge Amelyan drops to #2 and continues to stay all in cash adding only $3,000 in Bonus Bucks to his portfolio. Kevin is #1 with a total portfolio value of $3,471,377.82 up $422,904.60 from Friday's total. He gained $419,904.60 on the sale of Gentex Corp which was up 13.77% Monday.
One of the world's most prominent peer-reviewed medical journals is weighing in on last week's U.S. Supreme Court decision on abortion.